PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Vygon monitors provide improvement for ovarian cancer patients

Norfolk and Norwich University Hospitals have been using two Mostcare Up devices since 2019.

The complex procedure, Cytoreductive Surgery (CRS), is being directed by a haemodynamic monitor developed by Vygon. Critically, the technology has proved to reduce post-operative time and complications in a high-dependency unit by 45%.

Furthermore, a 21-hour reduction in length of stay in a high-dependency unit was recorded by Norfolk and Norwich University Hospitals. The institutions have been using two Mostcare Up devices in order to assist in CRS since 2019.

The technology monitors ‘beat-by-beat’ arterial blood pressure and, in turn, calculates in-depth haemodynamic parameters. This allows clinicians to precisely optimise fluid therapy, analyse a patient’s condition and – ultimately – deliver timely and appropriate treatment.

Fluid therapy is essential to reducing complications and therefore the Norfolk and Norwich team used goal-directed intra-operative fluid management (GDFM) to make life-saving decisions, following readings from Mostcare Up.

Data from over 100 patients demonstrated that a significantly higher amount of fluid was received intraoperatively. This included cases where over 23 litres had to be infused, based on the values observed from Mostcare Up. Consequently, the hospital has established a 100% reduction in respiratory or renal complications after the procedure.

Muzzamil Ali, a critical care specialist at Vygon, explained: “For these surgeries the blood loss is enormous and with such a fluid shift in a patient you need an accurate guide to make the right treatment decisions. That’s where Mostcare Up comes in.”

He added: “After initial use in the hospital’s gynaecology department, Mostcare Up is looking to be implemented in ICU. Because the equipment is intuitive and doesn’t require specialists to operate or interpret the results, it allows for nurse-led service. This frees up in-demand senior consultant time, so it’s really a win-win. Our feedback from the teams using it has been fantastic.”

Rocio Ochoa-Ferraro, a consultant at Norfolk and Norwich University Hospitals, reflected: “With this device, you get a better picture of how to treat your patients and you can target therapy to them. Most care Up makes it easier for our team to manage these difficult, challenging cases. And most importantly, the patients do better.”

He concluded: “It has changed our practice because using this monitor reduces the stress when dealing with difficult cases where you don’t know what you are dealing with from a cardiovascular or the cardiac point of view.”

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026